Full Professor of Radiation Oncology, University of Milan, Italy
Chair, Radiation Oncology Department and Proton Center, European Institute of Oncology (IEO), Milan, Italy
President of the European Society for Radiotherapy and Oncology (ESTRO), term 5/2026-5/2028
Chair of the Residency Programme in Radiation Oncology, University of Milan, Italy
Radiation oncologist with expertise in prostate cancer, SBRT, hypofractionation, proton therapy, AI & radiomics, and drug-radiation combinations. Actively involved in research projects and clinical trials with a focus on innovation and multidisciplinary collaboration.
Committed to education and advancing the radiation oncology field.
https://en.wikipedia.org/wiki/Barbara_Jereczek
https://www.linkedin.com/in/barbara-jereczek-fossa-55a9b015/
ORCID: 0000-0001-8151-3673
Disclosures:
- Employment: none
- Compensation: Janssen-Cilag, Bayer, Ipsen, Accuray, Astellas Pharma, Astra Zeneca, Pfizer, Accord, Novartis, Seagen, Daichii Sankyo, Radformation, Tecnologie Avanzate, IBA, Recordati: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria, Travel Expenses-End Date: to present ;ACCURAY, IBA, AIRC (Italian Association for Cancer Research), Fondazione IEO-CCM (Istituto Europeo di Oncologia-Centro Cardiologico Monzino): Research Grants, Research Funding, Research Salary Support, Gr
- Ownership: none
- Leadership: none